AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
5.85
+0.15 (2.63%)
Aug 14, 2026, 11:08 AM EDT - Market open
AdaptHealth Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 780 | 1,320 | 1,253 | 967 | 2,584 | 3,274 | |
Market Cap Growth | -38.19% | 5.30% | 29.64% | -62.58% | -21.08% | 14.00% |
Enterprise Value | 2,802 | 3,124 | 3,240 | 3,193 | 4,873 | 5,500 |
Last Close Price | 5.85 | 9.96 | 9.52 | 7.29 | 19.22 | 24.46 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 15.61 | - | 58.24 | 36.51 |
Forward PE | - | 11.60 | 9.91 | 9.86 | 15.29 | 15.36 |
PEG Ratio | - | 1.06 | 1.37 | 0.57 | 0.86 | 0.59 |
PS Ratio | 0.23 | 0.41 | 0.38 | 0.30 | 0.87 | 1.33 |
PB Ratio | 0.55 | 0.61 | 0.59 | 0.66 | 1.20 | 1.59 |
P/FCF Ratio | 7.78 | 6.02 | 5.32 | 6.75 | - | 45.24 |
P/OCF Ratio | 1.30 | 2.19 | 2.31 | 2.01 | 6.91 | 11.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.83 | 0.96 | 0.99 | 1.00 | 1.64 | 2.24 |
EV/EBITDA Ratio | 10.00 | 6.61 | 5.15 | - | 9.00 | 11.37 |
EV/EBIT Ratio | - | 34.38 | 12.28 | - | 25.59 | 24.38 |
EV/FCF Ratio | 28.48 | 14.24 | 13.74 | 22.29 | - | 75.99 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.92 | 0.85 | 0.97 | 1.50 | 1.05 | 1.11 |
Debt / EBITDA Ratio | 7.43 | 4.03 | 3.39 | - | 4.30 | 4.90 |
Debt / FCF Ratio | 21.14 | 8.67 | 9.04 | 16.02 | - | 32.76 |
Net Debt / Equity Ratio | 0.94 | 0.84 | 0.93 | 1.52 | 1.06 | 1.08 |
Net Debt / EBITDA Ratio | 7.27 | 3.80 | 3.15 | -10.28 | 4.22 | 4.59 |
Net Debt / FCF Ratio | 20.70 | 8.19 | 8.39 | 15.49 | -130.01 | 30.69 |
Asset Turnover | 0.75 | 0.74 | 0.73 | 0.66 | 0.57 | 0.69 |
Inventory Turnover | 24.88 | 21.12 | 20.36 | 21.34 | 19.06 | 22.09 |
Quick Ratio | 0.61 | 0.67 | 0.99 | 0.87 | 0.89 | 1.02 |
Current Ratio | 1.12 | 1.02 | 1.33 | 1.21 | 1.28 | 1.34 |
Return on Equity (ROE) | -6.66% | -3.07% | 5.26% | -37.24% | 3.46% | 13.47% |
Return on Assets (ROA) | -3.11% | 9.00% | 4.09% | -11.47% | 2.72% | 5.29% |
Return on Invested Capital (ROIC) | -3.24% | 9.81% | 4.71% | -13.73% | 3.26% | 7.08% |
Return on Capital Employed (ROCE) | -3.98% | 2.42% | 6.68% | -13.70% | 4.00% | 7.35% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | 6.41% | - | 1.72% | 2.74% |
FCF Yield | 12.85% | 16.62% | 18.81% | 14.81% | - | 2.21% |
Buyback Yield / Dilution | -0.40% | 0.28% | -0.83% | 36.01% | -57.89% | -153.46% |
Total Shareholder Return | -0.40% | 0.28% | -0.83% | 36.01% | -57.89% | -153.46% |